Impact of an Interleukin-1 Receptor Antagonist and Erythropoietin on Experimental Myocardial Ischemia/Reperfusion Injury

<table>Impact of Anakinra and erythropoietin on circulating inflammatory cytokines. Representative pictures demonstrating no differences in the relative expression levels of inflammatory cytokines depicted as black spots (<svg height="10.6875" id="M21" style="vertical-align:-0.0pt" version="1.1" viewbox="0 0 40.625 10.6875" width="40.625" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.6875)">
<g transform="translate(72,-63.45)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑁</tspan>
<tspan style="font-size: 12.50px; " x="14.103384" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="26.143772" y="0">4</tspan>
</text>
</g>
</g>
</svg> samples/group, + indicating positive control spots, − indicating negative control spots). Cytokine panel (top) published with kind permission of RayBiotech, Inc.</table>

The Scientific World Journal

fig3

Figure 3

Figure 3: Impact of an Interleukin-1 Receptor Antagonist and Erythropoietin on Experimental Myocardial Ischemia/Reperfusion Injury 